References
- Phillipson M Kubes P . The neutrophil in vascular inflammation. Nat. Med.17 (11), 1381–1390 (2011).
- Sadik CD Kim ND Luster AD . Neutrophils cascading their way to inflammation. Trends Immunol.32 (10), 452–460 (2011).
- Kruger P Saffarzadeh M Weber ANR et al. Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog.11 (3), (2015).
- Cascao R Rosario HS Souto-Carneiro MM Fonseca JE . Neutrophils in rheumatoid arthritis: more than simple final effectors. Autoimmun. Rev.9 (8), 531–535 (2010).
- Soehnlein O . Multiple roles for neutrophils in atherosclerosis. Circ. Res.110 (6), 875–888 (2012).
- Ferrari CC Tarelli R . Parkinson's disease and systemic inflammation. Parkinsons Dis. doi:10.4061/2011/436813 (2011) ( Epub ahead of print).
- Kucharzik T Walsh SV Chen J Parkos CA Nusrat A . Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am. J. Pathol.159 (6), 2001–2009 (2001).
- Cohen PR . Neutrophilic dermatoses a review of current treatment options. Am. J. Clin. Dermatol.10 (5), 301–312 (2009).
- Dong XY Chu DF Wang ZJ . Leukocyte-mediated delivery of nanotherapeutics in inflammatory and tumor sites. Theranostics7 (3), 751–763 (2017).
- Wang ZJ Li J Cho J Malik AB . Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat. Nanotechnol.9 (3), 204–210 (2014).
- Chu D Gao J Wang Z . Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection. ACS Nano9 (12), 11800–11811 (2015).
- Scheller J Chalaris A Schmidt-Arras D Rose-John S . The pro- and anti-inflammatory properties of the cytokine interleukin-6. Bba-Mol. Cell. Res.1813 (5), 878–888 (2011).
- Bradley JR . TNF-mediated inflammatory disease. J. Pathol.214 (2), 149–160 (2008).
- Grivennikov SI Greten FR Karin M . Immunity, inflammation, and cancer. Cell140 (6), 883–899 (2010).
- Singel KL Segal BH . Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. Immunol. Rev.273 (1), 329–343 (2016).
- Chu D Zhao Q Yu J Zhang F Zhang H Wang Z . Nanoparticle targeting of neutrophils for improved cancer immunotherapy. Adv. Healthc. Mater.5 (9), 1088–1093 (2016).
- Chu D Dong X Zhao Q Gu J Wang Z . Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration. Adv. Mater.29 (27), (2017).
- Castano AP Mroz P Hamblin MR . Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer6 (7), 535–545 (2006).
- Huang B Abraham WD Zheng Y Bustamante Lopez SC Luo SS Irvine DJ . Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells. Sci. Transl. Med.7 (291), 291–294 (2015).
- Smith BR Ghosn EE Rallapalli H et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat. Nanotechnol.9 (6), 481–487 (2014).
- Wang Z . Imaging nanotherapeutics in inflamed vasculature by intravital microscopy. Theranostics6 (13), 2431–2438 (2016).
- Xue J Zhao Z Zhang L et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol.12 (7), 692–700 (2017).
- Gao J Chu DF Wang ZJ . Cell membrane-formed nanovesicles for disease-targeted delivery. J. Control. Rel.224, 208–216 (2016).
- Chu DF Curdy C Riebesehl B Zhang Y Beck-Broichsitter M Kissel T . Enzyme-responsive surface erosion of poly(ethylene carbonate) for controlled drug release. Eur. J. Pharm. Biopharm.85 (3), 1232–1237 (2013).
- Liu WH Song JL Liu K Chu DF Li YX . Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease. J. Control. Rel.107 (3), 417–427 (2005).
- Wang Z Tiruppathi C Cho J Minshall RD Malik AB . Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life63 (8), 659–667 (2011).